AU1917201A - Amide therapeutics and methods for treating inflammatory bowel disease - Google Patents

Amide therapeutics and methods for treating inflammatory bowel disease

Info

Publication number
AU1917201A
AU1917201A AU19172/01A AU1917201A AU1917201A AU 1917201 A AU1917201 A AU 1917201A AU 19172/01 A AU19172/01 A AU 19172/01A AU 1917201 A AU1917201 A AU 1917201A AU 1917201 A AU1917201 A AU 1917201A
Authority
AU
Australia
Prior art keywords
therapeutics
amide
methods
inflammatory bowel
bowel disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19172/01A
Inventor
William D. Flitter
William A. Garland
Beverly Greenwood-Van Meerveld
Ian Irwin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centaur Pharmaceuticals Inc
Original Assignee
GREENWOOD VAN MEERVELD BEVERLY
Centaur Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GREENWOOD VAN MEERVELD BEVERLY, Centaur Pharmaceuticals Inc filed Critical GREENWOOD VAN MEERVELD BEVERLY
Publication of AU1917201A publication Critical patent/AU1917201A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU19172/01A 1999-11-18 2000-11-13 Amide therapeutics and methods for treating inflammatory bowel disease Abandoned AU1917201A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16638799P 1999-11-18 1999-11-18
US60166387 1999-11-18
PCT/US2000/031017 WO2001035950A2 (en) 1999-11-18 2000-11-13 Benzamide therapeutics and methods for treating inflammatory bowel disease

Publications (1)

Publication Number Publication Date
AU1917201A true AU1917201A (en) 2001-05-30

Family

ID=22603084

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19172/01A Abandoned AU1917201A (en) 1999-11-18 2000-11-13 Amide therapeutics and methods for treating inflammatory bowel disease

Country Status (3)

Country Link
US (1) US6486349B1 (en)
AU (1) AU1917201A (en)
WO (1) WO2001035950A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102764D0 (en) * 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
US20050059638A1 (en) * 2003-08-04 2005-03-17 Kelly Michael G. Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
US20050182060A1 (en) * 2004-02-13 2005-08-18 Kelly Michael G. 2-Substituted and 4-substituted aryl nitrone compounds
JP2007523905A (en) * 2004-02-18 2007-08-23 アストラゼネカ アクチボラグ Compound
WO2005080359A1 (en) * 2004-02-18 2005-09-01 Astrazeneca Ab Benzamide derivatives and their use as glucokinae activating agents
TW200600086A (en) * 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
GB0423044D0 (en) * 2004-10-16 2004-11-17 Astrazeneca Ab Compounds
JP2008516935A (en) 2004-10-16 2008-05-22 アストラゼネカ アクチボラグ Process for producing phenoxybenzamide compound
GB0423043D0 (en) * 2004-10-16 2004-11-17 Astrazeneca Ab Compounds
EP1891069A1 (en) * 2005-05-24 2008-02-27 AstraZeneca AB 2-phenyl substituted imidazol [4,5b]pyridine/ pyrazine and purine derivatives as glucokinase modulators
TW200714597A (en) * 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
EP2027113A1 (en) * 2005-07-09 2009-02-25 AstraZeneca AB Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
JP2009500442A (en) * 2005-07-09 2009-01-08 アストラゼネカ アクチボラグ 2-Heterocyclyloxybenzoylaminoheterocyclyl compounds as modulators of glucokinase for treating type 2 diabetes
AU2006268406C1 (en) * 2005-07-09 2011-02-24 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US9202182B2 (en) * 2005-08-11 2015-12-01 International Business Machines Corporation Method and system for analyzing business architecture
TW200738621A (en) * 2005-11-28 2007-10-16 Astrazeneca Ab Chemical process
TW200825063A (en) * 2006-10-23 2008-06-16 Astrazeneca Ab Chemical compounds
CL2007003061A1 (en) 2006-10-26 2008-08-01 Astrazeneca Ab COMPOUNDS DERIVED FROM 3,5-DIOXI-BENZAMIDA; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT A MEDIUM DISEASE THROUGH GLK, SUCH AS TYPE 2 DIABETES.
US20100094009A1 (en) * 2006-12-21 2010-04-15 Mccabe James Novel crystalline compound useful as glk activator
AU2009278929B2 (en) 2008-08-04 2012-07-05 Astrazeneca Ab Pyrazolo [3,4] pyrimidin-4-yl derivatives and their uses to treat diabetes and obesity
JP5424187B2 (en) * 2008-08-27 2014-02-26 学校法人 関西大学 Anticancer agent having acylaminophenyl group
GB0902434D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
GB0902406D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
AR076220A1 (en) 2009-04-09 2011-05-26 Astrazeneca Ab DERIVATIVES OF PIRAZOL [4,5 - E] PYRIMIDINE
AR076221A1 (en) 2009-04-09 2011-05-26 Astrazeneca Ab DERIVED FROM PIRAZOL [4,5-E] PYRIMIDINE AND ITS USE TO TREAT DIABETES AND OBESITY
WO2018156297A1 (en) * 2017-02-24 2018-08-30 Taiwanj Pharmaceuticals Co., Ltd Sulfonamide or amide compounds, compositions and methods for the prophylaxis and/or treatment of autoimmune, inflammation or infection related disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2049481A1 (en) * 1990-08-27 1992-02-28 Jill Ann Panetta Method of treating inflammatory bowel disease
US5672750A (en) * 1994-12-16 1997-09-30 Eastman Chemical Company Preparation of aromatic amides from carbon monoxide, an amine and an aromatic chloride
FR2735693B1 (en) * 1995-06-23 1997-09-26 Logeais Labor Jacques NEW THERAPEUTIC APPLICATIONS OF N-CYCLOHEXYL BENZAMIDES
US6271265B1 (en) * 1998-05-19 2001-08-07 Centaur Pharmaceuticals, Inc. Amide therapeutics for the treatment of inflammatory bowel disease

Also Published As

Publication number Publication date
WO2001035950A3 (en) 2001-11-29
US6486349B1 (en) 2002-11-26
WO2001035950A2 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
AU1917201A (en) Amide therapeutics and methods for treating inflammatory bowel disease
IL132145A0 (en) Methods and compositions for treating inflammatory bowel disease
AU2002232222A1 (en) Therapeutic Agents for Inflammatory Bowel Diseases
AU2446801A (en) Treatment for inflammatory bowel disease (ibd) and related conditions
EP1223932A4 (en) Compounds and methods
EP1146790A4 (en) Compounds and methods
EP1228264A4 (en) Improved aperture plate and methods for its construction and use
HRP20060251B1 (en) Substituted oxasolidinones and their use
AU4496800A (en) Laminin 2 and methods for its use
EP1165586A4 (en) TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS
HUP0301773A3 (en) Apomorphine derivatives and methods for their use
HU0001396D0 (en) 3-amino-3-arylpropan-1-al derivatives and their use
AU6386499A (en) Method and composition for treatment of inflammatory bowel disease
EP1194147A4 (en) Arylthiazolidinedione and aryloxazolidinedione derivatives
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
HUP0300689A3 (en) Method and compositions for treating an inflammatory disease
AU1917301A (en) Aryl nitrone therapeutics and methods for treating inflammatory bowel disease
EP1444983A4 (en) Agents for treating inflammatory bowel diseases
EP1079335A4 (en) Bill processor and its controlling method
IL147345A0 (en) Drosphila recombination- associated protein and methods for use
EP1229913A4 (en) Substituted 1-benzazepines and derivatives thereof
EP1066047A4 (en) Methods and materials for treating inflammatory diseases
AU4018201A (en) Molecules for diagnostics and therapeutics
GB9923117D0 (en) Insect-paper and methods for its formation and use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase